FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

7211000087109: FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
138001000087118 FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) en Fully specified name Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
22421000087110 TBE FSME-IMMUN BAG en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
22431000087112 FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (product) en Fully specified name Inactive Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
22441000087118 FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
74081000087110 ETT FSME-IMMUN BAG fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway French module (core metadata concept)
79201000087112 FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (product) fr Fully specified name Inactive Entire term case sensitive (core metadata concept) Canada Health Infoway French module (core metadata concept)

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) est un(e) (attribut) TBE tick-borne encephalitis unspecified true Inferred relationship Some
FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) est un(e) (attribut) Product manufactured as parenteral dose form (product) true Inferred relationship Some
FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) a pour principe actif (attribut) Inactivated whole Tick-borne encephalitis virus Neudorfl strain antigen true Inferred relationship Some 1
FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) Count of base of active ingredient un false Inferred relationship Some
FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) a une forme pharmaceutique (attribut) forme pharmaceutique pour usage parentéral (forme pharmaceutique) true Inferred relationship Some
FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) Plays role Active immunity stimulant role (role) true Inferred relationship Some
FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) Has supplier Baxter AG (supplier) true Inferred relationship Some
FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) est un(e) (attribut) Tick-borne encephalitis vaccine (product) false Inferred relationship Some
FSME-IMMUN 2.4 micrograms per 0.5 milliliter suspension for injection Baxter AG (real clinical drug) a pour principe actif (attribut) Tick-borne encephalitis vaccine (substance) false Inferred relationship Some 1
Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Historical name codes for vaccines reference set (foundation metadata concept)

Back to Start